PTC Therapeutics Inc

Common Name

PTC Therapeutics

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

939

Ticker

PTCT

Exchange

NASDAQ/NGS

Website

www.ptcbio.com

Description

Ptc Therapeutics Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of medicines focusing on rare genetic disorders. The primary objective of Ptc Therapeu... Show more

Financial Statements of PTC Therapeutics

Below are the financial statements of PTC Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	779.71^a	594^a
Marketable securities	359.99^a	282.74^a
Trade and royalty receivables, net	158.55^a	160.82^a
Inventory, net	23.19^a	30.58^a
Prepaid expenses and other current assets	44.09^a	150.49^a
Total current assets	1,365.53^a	1,218.63^a
Assets	—	—
Fixed assets, net	60.97^a	87.09^a
Intangible assets, net	118.79^a	379.5^a
Goodwill	82.34^a	82.34^a
Operating lease ROU assets	56.69^a	91.9^a
Deposits and other assets	20.7^a	36.25^a
Total assets	1,705.02^a	1,895.7^a
Current liabilities	—	—
Accounts payable and accrued expenses	304.29^a	391.98^a
Deferred revenue	5.51^a	0.8^a
Operating lease liabilities-current	10.36^a	13^a
Finance lease liabilities-current	3^a	3^a
Liability for sale of future royalties-current	257.82^a	194.31^a
Total current liabilities	580.98^a	603.1^a
Liabilities and stockholders’ deficit	—	—
Long-term debt	285.41^a	284.21^a
Contingent consideration payable	0.8^a	36.3^a
Deferred tax liability	0^a	55.91^a
Operating lease liabilities-noncurrent	74.95^a	97.63^a
Finance lease liabilities-noncurrent	15.57^a	17.18^a
Liability for sale of future royalties-noncurrent	1,823.96^a	1,619.78^a
Other long-term liabilities	21.43^a	0.14^a
Total liabilities	2,803.1^a	2,714.25^a
Stockholders’ deficit	—	—
Common stock	0.08^a	0.08^a
Additional paid-in capital	2,574.61^a	2,466.23^a
Accumulated other comprehensive loss	-25.89^a	-1.29^a
Accumulated deficit	-3,646.87^a	-3,283.58^a
Total stockholders’ deficit	-1,098.07^a	-818.56^a
Total liabilities and stockholders’ deficit	1,705.02^a	1,895.7^a

Verified Sources Behind PTC Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore PTC Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. PTC Therapeutics's Annual Report 2024

Trace every data point back to PTC Therapeutics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

PTC Therapeutics Inc

Financial Statements of PTC Therapeutics

Verified Sources Behind PTC Therapeutics’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

BioMarin Pharmaceutical Inc

Royalty Pharma PLC

Moderna Inc

Apellis Pharmaceuticals Inc

Bio-Techne Corp

Cytokinetics Inc